Axitinib in the Treatment of Head and Neck Malignancies

Publisher： Bentham Science Publishers

E-ISSN： 2212-3938|11|2|72-76

ISSN： 1574-8847

Source： Current Clinical Pharmacology, Vol.11, Iss.2, 2016-08, pp. : 72-76

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Malignancies of the head and neck: the role for molecular targeted agents

By Agulnik Mark  

Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 2, 2007-02 ,pp. : 207-217

Informa Healthcare

Access to resources Recommend Favorite

Review of current treatment practices for carcinoma of the head and neck

By Modi Bijal J   Knab Brian   Feldman Lawrence E   Mundt Arno J   Yao Mike   Pytynia Kristen B   Epstein Joel  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 7, 2005-06 ,pp. : 1143-1155

Informa Healthcare

Access to resources Recommend Favorite

Afatinib in the treatment of head and neck squamous cell carcinoma

By Ferrarotto Renata   Gold Kathryn A  

Expert Opinion on Investigational Drugs, Vol. 23, Iss. 1, 2014-01 ,pp. : 135-143

Informa Healthcare

Access to resources Recommend Favorite

Current and future directions in the treatment of squamous cell carcinoma of the head and neck: multidisciplinary symposium on head and neck cancer

By Haddad Robert  

Expert Opinion on Therapeutic Targets, Vol. 10, Iss. 2, 2006-04 ,pp. : 333-336

Informa Healthcare

Access to resources Recommend Favorite

Emerging molecular targeted therapies in the treatment of head and neck cancer

By Bozec Alexandre   Peyrade Frédéric   Fischel Jean-Louis   Milano Gérard  

Expert Opinion on Emerging Drugs, Vol. 14, Iss. 2, 2009-06 ,pp. : 299-310

Informa Healthcare

Access to resources Recommend Favorite